FIELD: medicine, phthisiology. SUBSTANCE: method involves prescription of ferrous sulfate oxide in therapeutic doses for some, at least, two days followed by its dosing with isonicotinic acid hydrazide preparation up to the end of treatment. Dose of ferrous sulfate oxide is at least by two- fold greater of the dose of isonicotinic acid hydrazide. Invention allows carrying out effective limitation of complications and adverse symptoms in treatment of tuberculosis and can be used for limitation of complications and adverse effects in treatment of tuberculosis. EFFECT: enhanced effectiveness of treatment. 2 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
METHOD OF REDUCING INTOLERANCE TO ANTITUBERCULOUS PREPARATIONS | 2009 |
|
RU2412701C2 |
SALT OF BIS(OXYMETHYL)PHOSPHINIC ACID WITH ISONICOTINIC ACID HYSRAZIDE (TUBOPHEN) HAVING ANTITUBERCULOSIS ACTION AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2281939C1 |
ISONICOTINOYLHYDRAZONES SHOWING ANTITUBERCULOSIS ACTIVITY | 1993 |
|
RU2054002C1 |
NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
METHOD FOR CORRECTION OF ISONIAZID-INDUCED HEPATOTOXIC REACTIONS | 2015 |
|
RU2601919C1 |
ISONICOTINIC ACID HYDRAZIDE OROTATE HAVING ANTIBACTERIAL AND IMMUNOTROPIC ACTIVITIES | 1990 |
|
RU2044728C1 |
METHOD FOR TREATING DIFFERENT FORMS OF PULMONARY TUBERCULOSIS, RESISTANT TO ANTITUBERCULAR CHEMOTHERAPY, AMONG THEM | 2001 |
|
RU2197984C1 |
HERB MIXTURE OF TREATMENT OF PULMONARY TUBERCULOSIS | 2009 |
|
RU2411954C2 |
AGENT HAVING ANTIHYPERTENSIVE EFFECT | 1987 |
|
RU2007169C1 |
Authors
Dates
2003-11-27—Published
2001-12-10—Filed